Genomics is probably the worst conceivable place
to be in biotechnology. There are no marketable products
coming out of that arena for the next thousand years
Man you are bold and cocky. I have followed your posts,
and you certainly seem like a smart fellow...but that
comment above?!
I was happy to see CRGN pull back a bit this morning,
and got some at $7...
Now I own AVGN, ARIA, BTRN, CORX, CRGN, GENE, GMED,
NTII, PARS and TGEN. Damn, that is a good lookin
portfolio, except for maybe one or two of the neuros.
Oh I also own quite a lot of Acclaim, AKLM, which is a
console and PC gaming stock...it is easier to understand than
biotech...and I needed some diversity in my portfolio:-)
Good luck out there...hope you make a few bucks on ODIS
yesterday.
Regards, Mike |
